News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
April, 2025
April 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
ESMO proposes principles to improve Sponsoring and Monitoring of Clinical Trials and promote patient welfare – Jose Luis Perez-Garcia
Photo taken from: Jose Luis Perez-Garcia / Twitter
Jul 20, 2023, 05:57

ESMO proposes principles to improve Sponsoring and Monitoring of Clinical Trials and promote patient welfare – Jose Luis Perez-Garcia

1/ Bureaucracy is overwhelming Clinical Research! ESMO proposes principles to improve Sponsoring and Monitoring of Clinical Trials and promote patient welfare.

Follow thread for examples & proposals, share if you agree!

https://bit.ly/3XZ63WY

 

Source: Jose Luis Perez-Garcia 

 

ESMO OncoDaily Oncology Research
Special Coverage
Blog
Apr 19, 2025, 21:21
Catherine Alix-Panabières: I’m thrilled to be attending the AACR 2025 in Chicago
Blog
Apr 19, 2025, 21:04
Jasmine Kamboj Hosts Policy Webinar with Expert Panel on May 2
Blog
Apr 19, 2025, 20:48
Palliative Care Knowledge in ICUs: Bilal Awad Publishes Q1 Research
Blog
Apr 19, 2025, 20:25
Breast Density Reporting Urged by Lobular Ireland Founder Siobhan Freeney
Blog
Apr 19, 2025, 20:05
Suzette DiMascio: I reflect on a moment that changed my life - and helped save another
Blog
Apr 19, 2025, 19:36
Pranati Yadlapalli Presents Nerve Injury Research at National Conference
Blog
Apr 19, 2025, 19:17
Yelak Biru: Rahul Banerjee on redefining 'cure' in myeloma
Science
Apr 19, 2025, 19:01
Stephen Liu: Perspective on unintended consequences of patient portal access
Blog
Apr 19, 2025, 18:46
Estela Rodriguez: Honored to join thought leaders seeking solutions in biomarker testing
Blog
Apr 19, 2025, 18:42
Pediatric Exercise Oncology Conference 2026: Save the Date - FORTEe
Insight
Apr 19, 2025, 18:29
ESMO living guidelines on metastatic breast cancer
Blog
Apr 19, 2025, 18:20
Todd Davis: Ligand Pharmaceuticals announces agreement to combine Pelthos with Channel Therapeutics